Sept 15- Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year.» Read More
April 1- France's Stallergenes said on Tuesday it received the U.S. Food and Drug Administration's green light to sell its immunotherapy pill Oralair for treating grass allergies. Oralair was approved in the European Union in 2008 and is also sold in Canada, Australia and Russia for the treatment of grass pollen allergy.
March 31- Curis Inc said the U.S. Food and Drug Administration allowed it to resume testing of its experimental cancer drug, lifting a November order halting enrolment in an early-stage trial. Curis acquired the license to develop and market the treatment from Genentech, a unit of the Roche Holding AG, for an upfront payment of $9.5 million in November 2012.
March 27- Baxter International Inc said it would spin off its biotechnology operations into a publicly traded company by the middle of next year, leaving behind its core medical technology business.
*Sanofi hopes to deliver first doses in late 2015. *Sanofi has spent over 1.3 bln euros on project.
Metal workers 2,000 years ago perfected plating techniques that modern methods can't touch. Some probably coated cheap metal or wood objects in a gilded skin and sold them for big profits. NBC reports.
The number of women choosing to have preventive mastectomies has risen by almost 50 percent in recent years, and surveys show they are happy with the decision.
China has earned praise from international scientists for its handling of an outbreak of a deadly new bird flu, but a history of public health cover-ups means the Chinese public is harder to win over.
A strain of bird flu that has been found in humans for the first time in eastern China is not a cause for panic, the World Health Organization said on Monday, even as the number of people infected rose to 21, with six deaths.
CNBC's Jon Fortt speaks with Facebook founder & CEO Mark Zuckerberg and Apple Chairman Art Levinson about a new foundation to offer a $33 million prize for life science research. "We all think our society needs more heroes who are scientists, researchers and engineers," he says.
Japan has one of the world’s highest suicide rates. But last year the number of suicides fell below 30,000 for the first time in 15 years, thanks in part to community efforts. The CSM reports.
Eli Lilly will be "very challenged" by the loss of exclusivity on several blockbuster drugs, CEO John Lechleiter told CNBC on Tuesday, but added the company can manage its growth in response.
The National Geographic Channel is preparing to beam tweets into space, in response to the "Wow! signal," a transmission received from space.
BGI, based in China, is the world’s largest genomics research institute, with 167 DNA sequencers producing the equivalent of 2,000 human genomes a day, the New York Times reports.
Scientists have discovered neural pathways that seem to correlate with the kinds of people who deal well with financial risk, but even the very definition of risk gets pulled apart by experts.
DSM Chairman and CEO Feike Sijbesma told CNBC he expects the Dutch chemicals firm to perform well in the second half of the year following strong second quarter results which saw a boost in net profit, while revenue fell just shy of the Reuters average forecast.